Ozempic is an injectable medication designed to assist people living with type 2 diabetes with weight loss. Additionally, it may prevent diabetic retinopathy – a condition that causes blood vessels to expand and block retinal blood vessels – from occurring.
Due to a shortage of semaglutide, the TGA has warned consumers that purchasing their medication from pharmacies only with a valid physician’s prescription will help them avoid scams and health risks.
Getting a Prescription
Due to a worldwide semaglutide shortage, Ozempic has been hard to come by recently; however, its availability will soon return, and until then, the medicines regulator has asked doctors to limit prescriptions of Ozempic for type 2 diabetes only. Diabetes Australia also advised healthcare professionals dealing with patients relying on Ozempic to manage their condition.
As the first step toward receiving an Ozempic prescription, arrange an in-person assessment with your healthcare professional – this may include your primary care doctor, endocrinologist, or diabetes specialist. At this appointment, they will conduct any necessary tests before discussing possible treatment options, including Ozempic. They can also help devise a health management plan.
TGA has approved overseas-registered semaglutide products to be supplied, although they are not subject to subsidization under the Pharmaceutical Benefits Scheme (PBS). At present, Australia’s leading weight loss startup, Eucalyptus, sells semaglutide; however, it should be noted that purchasing it online should not be done.
Buying Online
Ozempic is an innovative diabetes medication with the added ability to help users lose weight. Due to an exponential surge in demand, Novo Nordisk (the manufacturer) has not been able to keep up with supply, leading to worldwide shortages and forcing some consumers to purchase it online.
However, it’s essential that you purchase Ozempic from a reliable source. Unscrupulous companies may sell counterfeit drugs or mismanage customer data without your knowledge, risking both your health and privacy in the process. Be sure to read each company’s privacy policy thoroughly to make sure it suits your needs before making your purchase decision.
Australia’s healthcare regulator, the Therapeutic Goods Administration (TGA), has warned consumers against purchasing semaglutide online from websites selling it over-the-counter or selling on prescription. According to this agency, such sites could be fraudulent schemes designed to steal personal and credit card details for fraudulent use or sell them to third parties. For best results, it is advised to purchase semaglutide from Australian pharmacies with valid prescriptions only.
Buying in a Pharmacy
Ozempic is a prescription medication designed to assist those living with type 2 diabetes in managing their blood sugar levels and reducing weight. Unfortunately, due to an international shortage, its availability in Australian pharmacies is severely limited – creating serious concerns among patients living with chronic health conditions like diabetes and obesity. There are ways around the shortage, including accessing it via telemedicine services.
The first step to getting Ozempic is making an appointment with your healthcare provider and receiving tests and evaluation. If they determine that Ozempic is suitable, they will write you a prescription that can then be sent directly to your pharmacy. This process often takes days; however, some services offer expedited consultations at higher costs that should only be used for genuine medical needs and not financial gain; additionally, the Therapeutic Goods Advertising Authority regulates therapeutic goods advertising and will take action against anyone advertising unlicensed medicines.
Buying in a Store
Australians may experience difficulty in sourcing Ozempic, a diabetes medication with weight-loss effects, due to an explosion in demand. The Therapeutic Goods Administration cautions individuals to only purchase from licensed pharmacies with valid prescriptions; also, be wary when buying online as some scammers may try to steal personal data or make fraudulent purchases.
The TGA has been working closely with Novo Nordisk and pharmaceutical wholesalers to manage semaglutide (Ozempic). To manage supply, they have asked physicians not to initiate new patients on Ozempic until the shortage eases and prioritize its use for those patients with type 2 diabetes who are taking stable doses and for whom other options do not present suitable solutions.
Doctors are also advised to communicate directly with community pharmacies and patients in order to monitor stock availability as it becomes available. The Royal Australian College of General Practitioners issued updated advice for treating patients affected by shortages, while Diabetes Australia offered helpful tips.